Waning of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in 2020: A 12-month-evaluation in three population-based European studies

<strong>S. Novelli, C. Reinkemeyer, D. Bulaev et al.</strong>

<strong>Contributing partner:</strong>
INSERM, France

<strong>Scientific article available at:</strong>
<a href=”https://doi.org/10.1371/journal.pone.0320196″ rel=”noopener”>”PLOS One”</a>